A mildly high D-dimer at 72 is not interpreted the same way as the same number at 32. The hard part is knowing when age adjustment is safe — and when symptoms override the maths.
- تاقیکردنەوەی خوێنی D-dimer measures fibrin breakdown; a high result suggests clot formation and breakdown somewhere, but it does not prove a clot.
- Standard cutoff is often 500 ng/mL FEU, also written as 0.50 mg/L FEU, but labs use different units.
- Age-adjusted D-dimer cutoff after age 50 is usually age × 10 ng/mL FEU; a 78-year-old may have a cutoff of 780 ng/mL FEU.
- D-dimer cutoff by age should only be used when clinical probability is low or intermediate, not when symptoms strongly suggest pulmonary embolism or DVT.
- Urgent imaging is still needed for chest pain, sudden breathlessness, fainting, low oxygen, coughing blood, or a swollen painful leg, even with a borderline D-dimer.
- یەکای FEU لەگەڵ DDU matter because FEU values are roughly twice DDU values; 500 ng/mL FEU is about 250 ng/mL DDU.
- پیرترەکان often run higher because baseline fibrin turnover, vascular tissue response, kidney clearance changes, cancer risk, and infection rates rise with age.
- ئەنجامی سنووردار are safest when interpreted with Wells or Geneva score, oxygen saturation, pulse rate, risk factors, and timing of symptoms.
What a D-dimer blood test means after age 50
After age 50, a تاقیکردنەوەی خوێنی D-dimer can be interpreted with an age-adjusted cutoff: age × 10 ng/mL FEU. So a 70-year-old may be considered negative below 700 ng/mL FEU if clot probability is low or intermediate. But symptoms win. New breathlessness, chest pain, fainting, low oxygen, coughing blood, or one swollen painful leg still need urgent imaging, even when the number is only borderline.
I’m Thomas Klein, MD, and in clinical review work I see the same trap every week: a 76-year-old with a D-dimer of 620 ng/mL FEU is told it is “high,” then panics. At age 76, the age-adjusted cutoff is 760 ng/mL FEU, so 620 can be negative only when the clinical picture is reassuring.
A D-dimer result above 500 ng/mL FEU is common after 65, and that is why a fixed adult cutoff creates many false alarms. Our physician team, including reviewers listed on the desteya şêwirmendiya bijîşkî, treats D-dimer as a rule-out test, not a diagnosis.
Kantesti is an AI blood test analyzer that reads D-dimer alongside age, units, symptoms, pregnancy or surgery status, kidney markers, and inflammatory markers. That context matters because a 520 ng/mL FEU result in a calm 52-year-old is different from the same value in an 82-year-old with oxygen saturation of 90%.
Why D-dimer results often run higher as people age
D-dimer rises with age because older blood vessels and tissues have more background fibrin formation and breakdown. The rise is usually not one single problem; it is the combined effect of vascular aging, chronic inflammation, slower clearance, more medical procedures, and more silent illness.
By the late 60s, many healthy people have small increases in coagulation activation markers even without a deep vein thrombosis or pulmonary embolism. That does not mean the body is “full of clots”; it means the haemostatic system is noisier than it was at age 30.
The practical problem is specificity. In older adults, a fixed 500 ng/mL FEU cutoff can label a large proportion of non-clot illnesses as positive, especially pneumonia, heart failure, kidney impairment, cancer, trauma, and recent hospital admission. For a broader patient view, our ڕێژەی تەواوی D-dimer guide explains why “normal” is not always one number.
I often describe D-dimer as smoke, not fire. Smoke may come from a dangerous pulmonary embolism, but it may also come from a recent infection with CRP of 80 mg/L or a fall with bruising 5 days earlier. The number asks for clinical reasoning; it does not replace it.
How the age-adjusted D-dimer cutoff is calculated
ڕێژەی ڕەوتی age-adjusted D-dimer cutoff after 50 is age × 10 ng/mL FEU. A 60-year-old uses 600 ng/mL FEU, a 75-year-old uses 750 ng/mL FEU, and an 88-year-old uses 880 ng/mL FEU when the assay reports FEU units.
The ADJUST-PE study in JAMA found that age-adjusted cutoffs safely increased the number of older patients in whom pulmonary embolism could be ruled out without CT imaging (Righini et al., 2014). In patients 75 or older, the proportion ruled out by D-dimer rose from about 6.4% with the 500 ng/mL FEU cutoff to 29.7% using age adjustment.
Kantesti’s neural network treats this as D-dimer cutoff by age, not as a universal green light. A result of 690 ng/mL FEU at age 70 may be below the 700 cutoff, but only if the pretest probability is not high and the sample was taken before anticoagulation.
If you are comparing several biomarkers, age adjustment should sit beside the rest of the panel, not in a mental silo. Our ڕێنمای بیومارکر (biomarker guide) is built around that same principle: one result changes meaning when paired with age, kidney function, inflammation, and symptoms.
A useful bedside trick is to ignore the last digit of age and add a zero. Age 63 becomes about 630 ng/mL FEU; age 81 becomes about 810 ng/mL FEU. I still check the unit before saying anything reassuring.
FEU versus DDU units can double the apparent number
D-dimer reports are usually shown as FEU or DDU, and 500 ng/mL FEU is roughly equivalent to 250 ng/mL DDU. Misreading the unit can make a result look twice as high or falsely reassuring.
FEU means fibrinogen equivalent units; DDU means D-dimer units. Most age-adjusted formulas are published as ng/mL FEU, so the standard 500 ng/mL FEU cutoff becomes age × 10 after 50.
If your lab uses DDU, the rough equivalent age-adjusted cutoff is age × 5 ng/mL DDU. A 72-year-old cutoff would be about 720 ng/mL FEU or 360 ng/mL DDU, though assay-specific calibration still matters.
This is where many “D-dimer test results explained” summaries fail patients: they quote a single cutoff without unit conversion. Our ڕێنمای تاقیکردنەوەی کۆاگولیشن (coagulation testing)مان compares D-dimer with PT, INR, aPTT, and fibrinogen because clotting reports often arrive as a cluster.
Some European laboratories report mg/L FEU, where 0.50 mg/L FEU equals 500 ng/mL FEU. A report of 0.68 mg/L FEU at age 70 is 680 ng/mL FEU, which sits below the age-adjusted 700 ng/mL FEU cutoff if the clinical probability is low.
Age adjustment is safe only after pretest probability is checked
Age-adjusted D-dimer is validated for patients with low or intermediate clinical probability, not for people who already look likely to have a clot. Doctors usually combine symptoms, pulse, oxygen level, prior clot history, cancer, surgery, immobilisation, and exam findings before trusting the cutoff.
The 2019 European Society of Cardiology pulmonary embolism guideline supports D-dimer testing only in low or intermediate probability patients; high probability patients should generally proceed to imaging (Konstantinides et al., 2020). That distinction prevents a normal or borderline result from delaying diagnosis.
The PEGeD trial in the New England Journal of Medicine also showed that D-dimer can be adjusted to clinical probability, with higher thresholds used in low-risk patients under structured rules (Kearon et al., 2019). This is not “guesswork”; it is formal risk sorting.
For clinicians, Wells score remains a practical shorthand: signs of DVT, heart rate above 100/min, immobilisation, previous VTE, haemoptysis, cancer, and whether PE is the most likely diagnosis. Our research-style . لینکێکی ResearchGate: https://www.researchgate.net/. لینکێکی Academia.edu: https://www.academia.edu/. goes deeper into how D-dimer sits beside protein C and aPTT.
In my experience, the unsafe cases are rarely subtle in hindsight. A patient with pleuritic chest pain, tachycardia of 118/min, and oxygen saturation of 91% should not be reassured by a D-dimer of 610 ng/mL FEU at age 68.
Symptoms that still require urgent clot imaging
Urgent imaging is needed when symptoms suggest pulmonary embolism or deep vein thrombosis, even if D-dimer is borderline or below an age-adjusted cutoff. Sudden breathlessness, chest pain with breathing, fainting, low oxygen, coughing blood, rapid pulse, or one swollen painful leg should be treated as time-sensitive.
A pulmonary embolism can present with oxygen saturation below 92%, pulse above 100/min, sharp chest pain, new breathlessness, or collapse. A normal chest X-ray does not rule it out, and a borderline D-dimer does not make a high-risk story disappear.
In Kantesti clinical review, we flag symptom combinations rather than chasing the D-dimer number alone. A 58-year-old with a D-dimer of 540 ng/mL FEU and haemoptysis needs a different pathway than a 58-year-old with 540 after a mild viral illness and no cardiopulmonary symptoms.
Our deeper article on high D-dimer symptoms is useful because it separates laboratory risk from symptom risk. The two overlap, but they are not identical.
If you have severe breathlessness, fainting, blue lips, chest pressure, confusion, or a leg that is rapidly swelling, this is emergency territory. Do not wait 24 hours for a repeat D-dimer; imaging and clinical assessment are the safer next step.
One swollen leg can need ultrasound despite a borderline result
A single swollen, painful calf or thigh can still need venous ultrasound even when D-dimer is only mildly raised. DVT risk is higher when swelling is one-sided, new, tender, associated with warmth, or occurs after immobilisation, surgery, long travel, cancer, pregnancy, or prior clot.
DVT is not diagnosed by D-dimer; it is diagnosed by compression ultrasound in the right clinical setting. A proximal DVT in the thigh is usually more dangerous than an isolated calf clot because it has a higher chance of embolising to the lungs.
The clinical clue I trust most is asymmetry. A calf circumference difference of more than 3 cm, measured about 10 cm below the tibial tuberosity, is part of Wells scoring for DVT and changes the meaning of a borderline D-dimer.
Not all swelling is clot-related, of course. Low albumin, kidney disease, heart failure, lymphatic disease, and medication-related oedema can mimic or confuse the picture; our swelling lab clues guide covers those non-clot causes.
The tricky scenario is the older patient on a diuretic with chronic ankle swelling who notices one leg became worse over 48 hours. I would not let an age-adjusted D-dimer alone settle that case; ultrasound is cheap, fast, and often definitive.
Common non-clot reasons D-dimer is high in older adults
D-dimer can be high without a dangerous clot because many illnesses activate fibrin turnover. Infection, cancer, recent surgery, trauma, heart failure, kidney impairment, liver disease, inflammatory disorders, stroke, and hospitalisation can all push D-dimer above 500 ng/mL FEU.
The number tends to rise with severity. A mild chest infection may produce 700 ng/mL FEU, while sepsis, advanced cancer, or major trauma can produce several thousand ng/mL FEU without the result telling you exactly where the problem is.
Inflammation and coagulation talk to each other. When CRP is 100 mg/L and white blood cells are 16 × 10⁹/L, D-dimer may reflect systemic tissue response rather than a primary clot; our infection marker guide explains that pattern.
Kidney function matters too. Reduced eGFR can correlate with higher D-dimer partly because older, frailer patients have more vascular disease and inflammatory burden, and partly because clearance of several proteins becomes less predictable.
The clinical mistake is assuming “not a clot” means “nothing.” A D-dimer of 2,400 ng/mL FEU with fever, weight loss, anaemia, or abnormal liver enzymes still deserves work-up, just not necessarily a CT pulmonary angiogram as the first move.
Pregnancy, surgery, and infection change the rules
Age-adjusted D-dimer cutoffs are not a simple fit for pregnancy, the first weeks after surgery, or recent significant infection. In these settings, D-dimer often rises because coagulation and tissue repair are expected to be active.
After major surgery, D-dimer can remain elevated for days to weeks, sometimes above 1,000 ng/mL FEU even without a new clot. The exact timeline depends on tissue injury, immobility, infection, and whether preventive anticoagulation was used.
Pregnancy is a separate diagnostic pathway. D-dimer rises across trimesters, and clinicians may use pregnancy-adapted algorithms rather than the standard age × 10 rule; our article on pregnancy and surgery explains those exceptions.
COVID and other infections can leave a tail of raised D-dimer. A result of 900 ng/mL FEU 10 days after a febrile illness may reflect recovery, but new chest pain or falling oxygen saturation changes the risk immediately.
I try to pin down timing: symptom day 1, surgery day 14, flight day 3, fever day 7. D-dimer loses meaning when the timeline is vague because the same value can be harmless recovery noise or the early clue to a clot.
When D-dimer can look falsely reassuring
A D-dimer can be falsely low or less helpful if symptoms have been present for many days, anticoagulants were started before the test, the clot is small or isolated, or the assay has limited sensitivity. A negative result lowers risk; it does not erase a high-risk story.
D-dimer is most useful early in evaluation, before treatment. If someone took therapeutic anticoagulation for 24 to 48 hours before testing, the fibrin breakdown signal may fall enough to make interpretation less clean.
Symptoms that started 10 to 14 days earlier can also muddy the water. A clot may have stabilised, partially resolved, or produced less measurable D-dimer by the time the person finally attends clinic.
Kantesti is an AI-powered blood test analysis tool used by patients in more than 127 countries, but our outputs are designed to flag uncertainty rather than give a clot diagnosis. The ڕێنمایی تەکنەلۆژی explains how our system separates lab interpretation from emergency decision-making.
A clinician who hears “I fainted yesterday and now cannot walk across the room” should not be comforted by a borderline D-dimer. That case needs examination, oxygen measurement, ECG, and often imaging.
What urgent clot imaging usually involves
Urgent imaging for suspected pulmonary embolism is usually CT pulmonary angiography, V/Q scanning, or compression ultrasound depending on symptoms, pregnancy status, kidney function, contrast allergy, and local availability. The D-dimer result helps decide whether imaging is needed; it does not choose the scan by itself.
CT pulmonary angiography is fast and widely used, but it requires iodinated contrast and exposes the chest to radiation. In a patient with eGFR below 30 mL/min/1.73 m², contrast risk becomes part of the decision.
V/Q scanning can be useful when CT contrast is not ideal, particularly if the chest X-ray is normal. A leg ultrasound may confirm DVT and justify treatment without chest CT in selected cases.
Before imaging, doctors often check creatinine, eGFR, pregnancy status where relevant, oxygen saturation, ECG, and sometimes troponin or BNP if PE strain is suspected. Our ڕێنمایی ئەنجامی کلیە helps patients understand why renal numbers suddenly matter before contrast.
If imaging confirms PE, the next decision is severity. A small stable PE with oxygen saturation 97% is different from a large PE with low blood pressure, raised troponin, and right-heart strain.
How AI interpretation should handle D-dimer context
AI interpretation should treat D-dimer as a context-dependent marker, not as a binary high-or-normal label. The safest output considers age, units, assay type, timing, symptoms, risk factors, and related labs such as CRP, CBC, creatinine, platelets, PT/INR, and fibrinogen.
Kantesti is an AI lab test interpretation service that can identify when a D-dimer is above the lab’s fixed cutoff but below an age-adjusted threshold. That distinction is useful because many lab portals mark 510 ng/mL FEU as abnormal without explaining age.
The second layer is safety wording. If symptoms entered by the user include chest pain, shortness of breath, fainting, coughing blood, or unilateral leg swelling, the system should point toward urgent clinical evaluation rather than “watch and wait.”
Yên me لیمیتەکانی تێفسیرکردنی AI article is blunt about this: AI can explain patterns in about 60 seconds, but it cannot listen to your lungs, measure oxygen, or decide whether a CT scanner is needed tonight.
In my own review queue, the most useful AI flag is not “D-dimer high.” It is “D-dimer high for this age and paired with symptoms that raise clot probability,” which is a much more clinically honest sentence.
When repeating D-dimer helps — and when it wastes time
Repeating D-dimer can help when the original result was drawn too early, reported in confusing units, or obtained during a clear temporary trigger. Repeating it is not appropriate when current symptoms suggest PE or DVT; imaging should not be delayed for a second number.
A repeat test after 1 to 2 weeks can be reasonable when D-dimer was mildly raised during a viral illness and symptoms have fully settled. Falling from 1,100 to 520 ng/mL FEU can support recovery, though it still does not diagnose what happened.
Repeating is less helpful after surgery because values may stay high for several weeks. A stable patient 10 days post-operation needs risk assessment and sometimes ultrasound, not daily D-dimer checks.
Patients often ask for a second set of eyes when the portal says “abnormal” but the doctor says “not worrying.” Our دووبارە-بڕیار/بەدوای ڕای دوەم guide explains when that kind of review is useful and when same-day care is safer.
If you repeat D-dimer, repeat it in the same unit system if possible. Comparing 0.74 mg/L FEU with 390 ng/mL DDU without conversion is a recipe for confusion.
Questions to ask when your D-dimer is borderline
A borderline D-dimer should prompt better questions, not automatic reassurance or automatic CT scanning. Ask about the unit, your age-adjusted cutoff, your Wells or Geneva risk, symptom timing, recent triggers, and what symptom change should send you to urgent care.
The first question is simple: “Is this FEU or DDU?” The second is, “What cutoff applies for my age?” A 69-year-old with 640 ng/mL FEU may be below age-adjusted cutoff, while 640 ng/mL DDU is a different level of concern.
Then ask, “What was my clinical probability before the test?” If nobody considered pulse, oxygen saturation, one-sided leg swelling, recent surgery, estrogen therapy, cancer, or previous VTE, the result may have been interpreted too narrowly.
Ask for the plan in writing if you can: symptoms to watch, whether ultrasound is needed, whether CT is needed, and whether repeat testing makes sense. Our گۆڕاوەیی تاقیکردنەوەی خوێن guide helps patients understand why small lab shifts should not be read like stock prices.
I usually tell patients to keep three numbers handy: D-dimer value with unit, oxygen saturation if measured, and resting pulse. Those three numbers, paired with symptoms, often tell the clinician much more than the D-dimer flag alone.
Bottom line: use age adjustment, but do not ignore symptoms
Age-adjusted D-dimer after 50 is a smart way to reduce unnecessary imaging, but it is only safe inside a structured clinical assessment. Use age × 10 ng/mL FEU for many assays, verify the unit, and seek urgent care when symptoms suggest PE or DVT.
As of June 13, 2026, my practical rule is this: a low-risk 74-year-old with D-dimer 680 ng/mL FEU may avoid CT, but a breathless 74-year-old with pulse 120/min and oxygen 91% needs urgent assessment. The same number can mean different things.
Kantesti’s medical content is reviewed against clinical standards, not just lab reference intervals. Our pejirandina klînîkî page explains how physician oversight and technical benchmarking shape the way we present risk language.
If your D-dimer is borderline, do not argue with the number in isolation. Ask whether your age-adjusted cutoff was used, whether your symptoms change pretest probability, and whether ultrasound or CT is needed today.
The safe interpretation is humble. D-dimer is excellent at ruling out clots in the right patient group, poor at proving clots, and dangerous when used to overrule a high-risk clinical story.
Pirsên Pir tên Pirsîn
حد برش D-dimer بە تەعدیلکردنی تەمەن لە دوای ٥٠ ساڵ چەندە؟
کرانۀ معمولِ تعدیلشدۀ سنی برای D-dimer بعد از ۵۰ سالگی برابر است با سن × ۱۰ نانوگرم/میلیلیتر FEU. برای مثال، کرانۀ ۶۰۰ نانوگرم/میلیلیتر FEU در سن ۶۰ سالگی، ۷۵۰ نانوگرم/میلیلیتر FEU در سن ۷۵ سالگی، و ۸۸۰ نانوگرم/میلیلیتر FEU در سن ۸۸ سالگی است. این قاعده فقط زمانی باید استفاده شود که احتمال بالینیِ وجود لخته کم یا متوسط باشد، نه زمانی که علائم بهطور واضح به آمبولی ریه یا DVT اشاره میکنند.
آیا دیدایمر ۷۰۰ در یک فرد ۷۰ ساله بالا محسوب میشود؟
د-دایمرێک بە 700 نانوگرام/میلێلیتر FEU لە ڕاستەوخۆ لەسەر حدی سەرەتایی تایبەتی تەمەن-بەستراو بۆ کەسێکی 70 ساڵە. تەنها ئەگەر کەسەکە هەستیارییەکی کەم یان ناوەندی لە لەبەرچاوگرتنی کلینیکی هەبێت و هیچ نیشانە هەستیارەکانی تێدا نەبێت وەک بەهێزبوونی ناگهانی هەناسەبەستنی، دڵدرد/سینهدرد، هەڵکەوتن (غەشکردن)، کەمبوونی ئوکسۆژن، خوێنهەڵگرتن لە سینه (خۆن لەسەر سەرفە)، یان یەک لاگی یەکلایەنی پڕبوو و دێردەکەوتوو، دەتوانرێت وەک منفی چارەسەر بکرێت. ئەگەر یەکایەکە DDU بێت بەجای FEU، 700 نانوگرام/میلێلیتر DDU بە مانای یەکسان نییە و پێویستی بە تفسیرێکی جیاواز هەیە.
چرا D-dimer با افزایش سن زیاد میشود؟
D-dimer با افزایش سن زیاد میشود، چون تشکیل و تجزیهٔ پایهای فیبرین با پیرشدن رگهای خونی، بافتها و سامانههای التهابی فعالتر میگردد. افراد مسن همچنین نرخهای بالاتری از عفونت، سرطان، نارسایی کلیه، نارسایی قلب، جراحی و بستری در بیمارستان دارند؛ همهٔ این موارد میتوانند D-dimer را بدون اثبات وجود لخته، بالاتر از 500 ng/mL FEU ببرند. به همین دلیل، آستانههای تعدیلشده بر اساس سن، نتایج مثبت کاذب را بعد از 50 سالگی کاهش میدهند.
آیا یک D-dimer معمولیِ تعدیلشده بر اساس سن میتواند لخته را از قلم بیندازد؟
Yes, a normal age-adjusted D-dimer can miss a clot in selected situations, especially if clinical probability is high, symptoms have been present for 10 to 14 days, anticoagulants were started before testing, or the clot is small. D-dimer is safest as a rule-out test in low or intermediate risk patients. High-risk symptoms should lead to imaging rather than reassurance from a borderline number.
کدام نشانهها نیاز به وێنەبرداری دارند حتی با د-دایمری حدی؟
هەناسە تێکچوونی ناگهانی، دڵدرد کە لەگەڵ هەناسەهەڵدان بەهێزتر دەبێت، هەڵوەشاندن/غەشبوون، سەچڕانی ئوکسژین لە نزیکەی 92%، خوێن لە سەروو/سەرفەڕەدا، پالس زیاتر لە 100/لەکە، یان یەک پێی پڕبوو و لەسەرەوە لەدرد میتواند بۆ وێنەبردنی فورسەیی ڕەوا بێت هەرچەندە ئەنجامی D-dimer لە سنووری کەمێک بێت. وێنەبردن دەتوانێت واتای تێکچوونی شریانەیی لە رێگای CT بۆ شریانەی خۆڵی (CT pulmonary angiography)، وێنەبردنی V/Q، یان سونۆگرافی فشاری (compression ultrasound) بێت بە پێی دۆخی کلینیکی. ئەنجامی D-dimer نابێت ڕێگری بکات لە بەرامبەر ڕەنگدانەوەی ڕێژەی خەتەر-بەرز لە شێوەی نەخۆشی.
تفاوت بین FEU و DDU در نتایج D-dimer چیست؟
FEU and DDU are different reporting systems for D-dimer, and FEU values are roughly twice DDU values. A standard cutoff of 500 ng/mL FEU is approximately equivalent to 250 ng/mL DDU. Age-adjusted formulas are usually written for FEU as age × 10 ng/mL after age 50, while a rough DDU equivalent is age × 5 ng/mL.
آیا باید یک آزمایش D-dimer مرزی را دوباره تکرار کنم؟
تکرار کردن D-dimer حد مرزی میتواند منطقی باشد زمانیکه نشانهها کمخطر هستند، واحد اولیه نامشخص بوده است، یا نتیجه در زمان یک محرک موقت مانند یک عفونت خفیف رخ داده است. تکرار پس از ۱ تا ۲ هفته ممکن است نشان دهد که مقدار در حال کاهش است یا نه؛ برای نمونه از ۱٬۱۰۰ به ۵۲۰ نانوگرم/میلیلیتر FEU. اگر درد قفسه سینه، تنگی نفس، غش، اکسیژن پایین، یا یک پا که ورمکرده و دردناک است دارید، منتظر انجام آزمایش تکراری نمانید.
ئەمڕۆ AI-پاوەرد لەسەر تاقیکردنەوەی خوێن بەدەست بهێنە
بە یارمەتی زیاتر لە 2 ملیۆن بەکارهێنەر لە هەموو جیهاندا کە Kantesti دەستپێدەکەن بۆ تاقیکردنەوەی لابراتۆری ڕاست و بەهێز لە کاتێکی کەم. ڕەخنەی تاقیکردنەوەی خوێنت بنێرە و تفسیرێکی تەواو لە 15,000+ نیشانەی زیستی (biomarkers) لە ماوەی چرکەکاندا وەرگرە.
📚 توێژینەوە سەرچاوە پەیوەندیدارەکان
Klein, T., Mitchell, S., & Weber, H. (2026). Rêbera Tenduristiya Jinan: Ovulasyon, Menopoz û Nîşaneyên Hormonal. Kantesti توێژینەوەی پزیشکی AI.
Klein, T., Mitchell, S., & Weber, H. (2026). Multilingual AI Assisted Clinical Decision Support for Early Hantavirus Triage: Design, Engineering Validation, and Real-World Deployment Across 50,000 Interpreted Blood Test Reports. Kantesti توێژینەوەی پزیشکی AI.
📖 سەرچاوەی پزیشکی دەرەکی
⚕️ Daxuyaniya Bijîşkî
ئەم مادەیە تەنها بۆ. I think I must continue but user expects all items.
E-E-A-T Trust Signals
Tecribe
Physician-led clinical review of lab interpretation workflows.
Pisporî
Laboratory medicine focus on how biomarkers behave in clinical context.
Desthilatdarî
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Bawerî
Evidence-based interpretation with clear follow-up pathways to reduce alarm.